-
Japanese Researchers Create Novel Delivery Approach for Targeted Mesothelioma Treatment
In the last several years, targeted therapies have shown great promise in the treatment of malignant pleural mesothelioma, but the rare, asbestos-related form of cancer continues to claim lives. In an attempt to find a more effective method of delivering these state-of-the-art drugs, researchers from the Hyogo College of Medicine have developed a minimally invasive,
-
Navy Veteran’s Mesothelioma Death Blamed on Asbestos in Boilers
Jerome J. Gehant served in the Navy for less than four years, but that short stint is being blamed for his malignant mesothelioma death. Gehant worked on just one ship – the USS America — and his only duty was service as a boiler technician. His family blames his illness and subsequent death on asbestos in the insulation,
-
Judge Rebukes “Unreasonably Lengthy and Redundant” Deposition of 84-Year-Old Mesothelioma Victim
Asbestos companies make use of numerous questionable strategies while defending themselves against mesothelioma claims. They delay proceedings knowing that mesothelioma patients may die from the aggressive form of cancer before their case goes to court, and they’ve been known to put frail plaintiffs through exceedingly long hours of testimony. Following a recent episode, a New
-
Jones Act Asbestos-Related Cancer Claim Survives Motion to Dismiss
The statute of limitations in mesothelioma lawsuits and other similar personal injury cases is three years from when the victim knows or should have known of their illness. Though this may seem clear cut, asbestos companies often try to use this limitation to their advantage to have cases dismissed. A recent attempt to have a
-
Report Exposes Role of Rubber Factories in Mesothelioma and Other Asbestos-Related Diseases
Malignant mesothelioma is a rare and deadly form of cancer caused by exposure to asbestos. It is largely linked to occupational exposure to the carcinogen, and many of its victims worked with insulation or construction materials, or in high-heat settings. One group of those exposed to asbestos are the former employees of rubber factories in
-
North Carolina Mesothelioma Victim Files Suit Against Multiple Asbestos Companies
More than forty years after Augustus A. Adams left his work at the Kinston, North Carolina E.I. DuPont de Nemours & Company plant, he was diagnosed with malignant mesothelioma. He and his wife Diane filed suit against a long list of companies whose products he blames for having exposed him to asbestos fibers and causing
-
Asbestos Company Fails in Bid to Overturn $13.5 Million Mesothelioma Verdict
In 2020, Raymond Budd and his wife Vickie filed a lawsuit accusing Kaiser Gypsum Company of negligence in failing to warn about the asbestos in their joint compound that they believe caused Raymond’s malignant mesothelioma. After the couple won a $13.5 million verdict, Kaiser moved for dismissal of the verdict and called for a new
-
Cancer Pill Delivers Promising Results in Mesothelioma Patients
Medical oncologists at Memorial Sloan Kettering Cancer Center in New York have just completed a phase 2 clinical trial that has delivered promising results for many patients with malignant mesothelioma. Researchers at the esteemed medical facility found that a drug called tazemetostat delivers significant disease control for the more than 50% of pleural mesothelioma patients
-
Mistakes in Identifying Mesothelioma Subtype Can Have Critical Impact
When it comes to treating malignant mesothelioma, it is important that patients receive the best care possible. Seeking medical treatment from physicians who are experienced in treating the rare and aggressive form of cancer makes an enormous difference, both in terms of availability of state-of-the-art treatment and in ensuring that testing is done with meticulous
-
CDC Reports Increasing Mesothelioma Deaths Among Women
Malignant mesothelioma is a rare and dangerous form of cancer caused by exposure to asbestos. Because of its direct link to the toxic material, which has long been used in construction, insulation, and high-heat settings, it is generally considered an occupational disease and has traditionally been most prevalent in men. But a recent report published
-
Humor Can Trigger Both Grief and Relief for Families of Mesothelioma Victims
Despite the best efforts of researchers and physicians, malignant mesothelioma remains an aggressive and relentless form of cancer, often moving so quickly that it claims the lives of patients within months of diagnosis. The loved ones left behind experience emotions ranging from sadness and loss to intense anger at the asbestos companies that could have
-
Mesothelioma Advocates Praise Latest EPA Asbestos Proposal
Exposure to asbestos claims almost 40,000 American lives every year from diseases including malignant mesothelioma and asbestosis. After years of legal challenges, the last few weeks has seen a flurry of activity coming out of the Environmental Protection Agency regarding the deadly mineral, and the most recent is being applauded by a leading awareness and
-
Federal Court Reverses Decision in Mesothelioma Widow’s Wrongful Death Claim
Surviving families of mesothelioma victims won a significant victory in federal court this week. In reversing a lower court decision, the U.S. Court of Appeals for the Ninth Circuit confirmed and clarified that wrongful death claims do not begin to accrue until the time of the victim’s death.
-
Israeli Mesothelioma Drug Study Yields Substantial Survival Benefit
A presentation delivered to the International Society for Cell and Gene Therapy’s annual meeting is being greeted with enthusiasm by mesothelioma physicians and researchers. An Israeli immunotherapy company revealed that their clinical-stage macrophage reprogramming drug Allocetra delivered up to 100% survival in laboratory animals.
-
Mesothelioma Patients Treated with New Protocol Enjoy Longer Survival
Malignant mesothelioma is an extremely aggressive disease, and physicians and researchers have struggled to find effective treatments. Once diagnosed, patients rarely live longer than a year-and-a-half. But patients enrolled in a clinical trial in the United Kingdom are experiencing significant benefits, with some living more than five years.
-
Immunotherapy Study Yields Results That May Prove Vital for Mesothelioma Patients
A recently published study of cancer drug toxicity may prove beneficial to patients being treated for malignant mesothelioma. Patients diagnosed with the rare asbestos-related disease have responded well to a variety of immunotherapy treatments, but serious adverse effects have forced many patients to discontinue treatment. UK researchers have discovered what causes these effects and have
-
Insurance Company Fails to Quash Mesothelioma Victim’s Claim
Callen Cortez blames his malignant mesothelioma diagnosis on multiple sources of exposure to asbestos. In addition to his own workplace, he also claims to have suffered take-home exposure from his brothers’ employment, and from his father’s as well. When he sought compensation for his injuries, the insurer for his father’s employer filed a motion for
-
ICI Use Provides Mesothelioma Patients with Lower Risk of Neurologic Adverse Effects
A diagnosis of malignant mesothelioma is a shock, and the more that you learn about the illness, the more frightening it becomes. Patients and their loved ones have many concerns, including side effects from the treatments used to prolong their lives. Now researchers have found that the use of immune checkpoint inhibitors significantly lowers the
-
UK Study Examines Mesothelioma Nurses’ Role in Palliative Care
The United Kingdom has one of the highest rates of malignant mesothelioma in the world. Treating these patients is a top priority for the nation’s health care professionals, and specially trained mesothelioma clinical nurse specialists (MCNSs) play a crucial role. A recent study examined these practitioners’ perspectives on providing palliative care for patients diagnosed with
-
Chemical Companies Fight for Asbestos Use, Despite Mesothelioma Concerns
While asbestos awareness advocates and those touched by mesothelioma were cheered by news of a proposed asbestos ban, the chemical industry continues to fight the move. Instead of working to retrofit their factories in ways that would prevent future asbestos-related disease, industry groups are stoking fears of job losses and unclean water.
